These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12756634)

  • 21. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
    Matzdorff A; Voss R
    Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptor.
    Weisman HF; Schaible TF; Jordan RE; Cabot CF; Anderson KM
    Biochem Soc Trans; 1995 Nov; 23(4):1051-7. PubMed ID: 8654680
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis.
    Abulencia JP; Tien N; McCarty OJ; Plymire D; Mousa SA; Konstantopoulos K
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):149-56. PubMed ID: 11145947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
    Rote WE; Nedelman MA; Mu DX; Manley PJ; Weisman H; Cunningham MR; Lucchesi BR
    Stroke; 1994 Jun; 25(6):1223-32; discussion 1233. PubMed ID: 8202985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor.
    Sitges M; Villa FP
    Int J Cardiol; 1997 Dec; 62(3):269-71. PubMed ID: 9476687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abciximab (ReoPro) removal with a hemoconcentrator during cardiopulmonary bypass.
    Lemmer JH
    J Thorac Cardiovasc Surg; 1999 Nov; 118(5):980-1. PubMed ID: 10534719
    [No Abstract]   [Full Text] [Related]  

  • 28. Activating effects of GPIIb/IIIa blockers: an intrinsic consequence of ligand-mimetic properties.
    Peter K; Schwarz M; Bode C
    Circulation; 2002 May; 105(21):E180-1. PubMed ID: 12034670
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor.
    Frishman WH; Burns B; Atac B; Alturk N; Altajar B; Lerrick K
    Am Heart J; 1995 Oct; 130(4):877-92. PubMed ID: 7572600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effects of the glycoprotein IIb/IIIa receptor antagonists abciximab and eptifibatide on platelet aggregation in healthy cats.
    Magee AN; Hogan DF; Sederquist KA; Durham JA
    Am J Vet Res; 2014 Mar; 75(3):309-12. PubMed ID: 24564318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
    Hosokawa K; Ohnishi T; Fukasawa M; Kondo T; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Microvasc Res; 2012 Mar; 83(2):154-61. PubMed ID: 22166857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of recurrent thrombocytopenia due to abciximab.
    Sharma V; Mascarenhas D
    J Invasive Cardiol; 2004 Sep; 16(9):537-8. PubMed ID: 15353816
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet receptors.
    Blom P; Korona M; Haikal L
    AJNR Am J Neuroradiol; 2006 Jan; 27(1):8-9; author reply 9. PubMed ID: 16418346
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
    Nurden AT; Poujol C; Durrieu-Jais C; Nurden P
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2835-40. PubMed ID: 10591658
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist.
    Savi P; Bernat A; Lalé A; Roque C; Zamboni G; Herbert JM
    Platelets; 2000 Feb; 11(1):43-8. PubMed ID: 10938881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.
    Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
    Angiology; 2000 Nov; 51(11):913-23. PubMed ID: 11103860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
    J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus.
    Coiffic A; Cazes E; Janvier G; Forestier F; Lanza F; Nurden A; Nurden P
    Thromb Res; 1999 Jul; 95(2):83-91. PubMed ID: 10418797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic effects of abciximab.
    Hayes R; Chesebro JH; Fuster V; Dangas G; Fallon JT; Sharma SK; Coller BS; Badimon L; Marmur JD; Badimon JJ
    Am J Cardiol; 2000 May; 85(10):1167-72. PubMed ID: 10801995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.